Geode Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-93,934	Closed	-$3.98M	–	4645
2024 Q1	$3.98M	Buy	93,934 +1,121	+1%	+$47.2K	﹤0.01%	2823
2023 Q4	$3.88M	Buy	92,813 +4,340	+5%	+$160K	﹤0.01%	2832
2023 Q3	$3.34M	Buy	88,473 +5,937	+7%	+$223K	﹤0.01%	2848
2023 Q2	$3.13M	Buy	+82,536	New	+$2.59M	﹤0.01%	2946
2020 Q1	–	Sell	-7,650	Closed	-$671K	–	4187
2019 Q4	$671K	Sell	7,650 -10,786	-59%	-$910K	﹤0.01%	3414
2019 Q3	$1.39M	Buy	18,436 +2,743	+17%	+$223K	﹤0.01%	3111
2019 Q2	$1.34M	Buy	15,693 +4,586	+41%	+$454K	﹤0.01%	3133
2019 Q1	$1.2M	Buy	11,107 +3,852	+53%	+$384K	﹤0.01%	3086
2018 Q4	$613K	Buy	7,255 +4,018	+124%	+$387K	﹤0.01%	3296
2018 Q3	$318K	Buy	3,237 +398	+14%	+$43.1K	﹤0.01%	3606
2018 Q2	$327K	Buy	2,839 +347	+14%	+$38.1K	﹤0.01%	3567
2018 Q1	$245K	Sell	2,492 -2,406	-49%	-$244K	﹤0.01%	3622
2017 Q4	$511K	Sell	4,898 -30,739	-86%	-$3.38M	﹤0.01%	3353
2017 Q3	$4M	Buy	35,637 +398	+1%	+$43.3K	﹤0.01%	2340
2017 Q2	$3.94M	Buy	35,239 +4,160	+13%	+$470K	﹤0.01%	2305
2017 Q1	$3.62M	Buy	31,079 +2,295	+8%	+$254K	﹤0.01%	2302
2016 Q4	$3.03M	Sell	28,784 -603	-2%	-$63.2K	﹤0.01%	2387
2016 Q3	$3.24M	Buy	29,387 +3,272	+13%	+$433K	﹤0.01%	2246
2016 Q2	$3.79M	Buy	26,115 +12,298	+89%	+$1.74M	﹤0.01%	2098
2016 Q1	$1.97K	Buy	13,817 +1,008	+8%	+$143K	﹤0.01%	2469
2015 Q4	$1.97M	Buy	+12,809	New	+$1.87M	﹤0.01%	2500
2015 Q3	–	Sell	-2,463	Closed	-$353K	–	4138
2015 Q2	$353K	Sell	2,463 -541	-18%	-$77.2K	﹤0.01%	3357
2015 Q1	$423K	Sell	3,004 -5,050	-63%	-$777K	﹤0.01%	3259
2014 Q4	$1.19M	Buy	8,054 +5,320	+195%	+$782K	﹤0.01%	2738
2014 Q3	$420K	Buy	+2,734	New	+$412K	﹤0.01%	3243